Data Collective IV GP, LLC
Long book
$55.9M
Q1 2026
Positions
4
Top-10 weight
100%
concentration
Last quarter
+38.4%
SPY +14.8%
Turnover
60%
of book per quarter
Strategy in plain words
auto-generated from filingsData Collective IV GP, LLC is a diversified fundamental manager, specialised in technology (64% of the long book), running a $55.9M US long book across 4 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: EVOLV TECHNOLOGIES HOLDINGS, RECURSION PHARMACEUTICALS-A, HORIZON QUANTUM HOLDING-CL A, DEFINIUM THERAPEUTICS INC.
Over the last 9 quarters its long book ran on average 7.5pp per quarter ahead of the S&P 500, beating the index in 4 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-32.3%
Q2 2024
+5.1%
Q3 2024
+67.7%
Q4 2024
-7.7%
Q1 2025
+46.8%
Q2 2025
+19.2%
Q3 2025
-9.9%
Q4 2025
-19.5%
Q1 2026
+38.4%
Sector allocation
Technology 64%
Healthcare 33%
Materials 3%
Long book by quarter
What does Data Collective own?
Q1 2026 13F13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 4 | $55.9M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 3 | $58.5M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 4 | $68.0M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 5 | $129.9M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 15, 2025 | 5 | $86.9M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 6 | $226.3M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 6 | $163.5M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 6 | $142.7M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 5 | $115.3M | canonical | SEC ↗ |